Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2018-09-10
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sarcopenia Screening in Elderly Individuals
NCT06012422
Sarcopenia And Balance In Postmenopausal Osteoporosis
NCT03832088
Evaluation of Sarcopenia in Women in Different Stages of Life and in Hormonal Therapy or Not
NCT06792201
Prevalence of Sarcopenia-Promoting Medicines in Patients With Sarcopenia and Falls
NCT07127692
Comparison of Lumbar Muscle Thickness Measurements in Osteoporotic and Osteopenic Patients
NCT05823558
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Elderly with sarcopenia
50 patients aged 75 or older with sarcopenia Intervention: Each patient's supine and standing blood pressures will be measured.
blood pressure measurement
Intervention: Each patient's supine and standing blood pressure measurements will be recorded
Elderly without sarcopenia
50 patients aged 75 or older without sarcopenia Intervention: Each patient's supine and standing blood pressures will be measured.
blood pressure measurement
Intervention: Each patient's supine and standing blood pressure measurements will be recorded
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood pressure measurement
Intervention: Each patient's supine and standing blood pressure measurements will be recorded
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* End stage renal insufficiency
* End stage malignancy
* Dehydration
* Severe anemia ( Hgb \< 8 gr/dl)
* Acute infection
* Marked edema
* Neurodegenerative disease
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sisli Hamidiye Etfal Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kudret Keskin
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kadriye Orta Kılıçkesmez, Prof
Role: STUDY_DIRECTOR
Şişli Hamidiye Etfal Education and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Şişli Hamidiye Etfal Education and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Hashimoto Y, Kaji A, Sakai R, Hamaguchi M, Okada H, Ushigome E, Asano M, Yamazaki M, Fukui M. Sarcopenia is associated with blood pressure variability in older patients with type 2 diabetes: A cross-sectional study of the KAMOGAWA-DM cohort study. Geriatr Gerontol Int. 2018 Sep;18(9):1345-1349. doi: 10.1111/ggi.13487. Epub 2018 Jul 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.